2,436
Views
191
CrossRef citations to date
0
Altmetric
Reviews

Molecular mechanisms for enhanced DNA vaccine immunogenicity

& ORCID Icon
Pages 313-329 | Received 31 Aug 2015, Accepted 23 Nov 2015, Published online: 28 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Xirui Zhang, Hao Yuan, Yasser S. Mahmmod, Zipeng Yang, Mengpo Zhao, Yining Song, Shengjun Luo, Xiu-Xiang Zhang & Zi-Guo Yuan. (2023) Insight into the current Toxoplasma gondii DNA vaccine: a review article. Expert Review of Vaccines 22:1, pages 66-89.
Read now
Sijia Li, Weiwei Li, Yinqi Jin, Bin Wu & Yimou Wu. (2023) Advancements in the development of nucleic acid vaccines for syphilis prevention and control. Human Vaccines & Immunotherapeutics 19:2.
Read now
Hiba Hussain, Aishwarya Ganesh, Lara Milane & Mansoor Amiji. (2023) Lessons learned from the SARS-CoV-2 pandemic; from nucleic acid nanomedicines, to clinical trials, herd immunity, and the vaccination divide. Expert Opinion on Drug Delivery 20:4, pages 489-506.
Read now
Yu Wang, Weiwei Song, Qiang Xu, Yachao Liu, Hezhong Liu, Runzi Guo, Chuang-Jiun Chiou, Kun Gao, Baofeng Jin, Changfeng Chen, Zhongming Li, Jinqi Yan & Jiyun Yu. (2023) Adjuvant DNA vaccine pNMM promotes enhanced specific immunity and anti-tumor effects. Human Vaccines & Immunotherapeutics 19:1.
Read now
Vivek P Chavda, Radhika Pandya & Vasso Apostolopoulos. (2021) DNA vaccines for SARS-CoV-2: toward third-generation vaccination era. Expert Review of Vaccines 20:12, pages 1549-1560.
Read now
Subhadip Choudhuri, Lizette Rios, Juan Carlos Vázquez-Chagoyán & Nisha Jain Garg. (2021) Oxidative stress implications for therapeutic vaccine development against Chagas disease. Expert Review of Vaccines 20:11, pages 1395-1406.
Read now
Mark Verdecia, John F. Kokai-Kun, Maura Kibbey, Sarita Acharya, Jaap Venema & Fouad Atouf. (2021) COVID-19 vaccine platforms: Delivering on a promise?. Human Vaccines & Immunotherapeutics 17:9, pages 2873-2893.
Read now
Crystal Ma & Wangxue Chen. (2021) Where are we and how far is there to go in the development of an Acinetobacter vaccine?. Expert Review of Vaccines 20:3, pages 281-295.
Read now
Xinle Cui & Clifford M. Snapper. (2019) Development of novel vaccines against human cytomegalovirus. Human Vaccines & Immunotherapeutics 15:11, pages 2673-2683.
Read now
Charlotte Switzer, Lorne Babiuk & Mark Loeb. (2019) Determining optimal community protection strategies for the influenza vaccine. Expert Review of Vaccines 18:8, pages 755-764.
Read now
Don Jeffrey Diamond, Corinna La Rosa, Flavia Chiuppesi, Heidi Contreras, Sanjeet Dadwal, Felix Wussow, Supriya Bautista, Ryotaro Nakamura & John A. Zaia. (2018) A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection. Expert Review of Vaccines 17:10, pages 889-911.
Read now
Fu-Sheng Gao, Yu-Tao Zhan, Xu-Dong Wang & Chuan Zhang. (2018) Enhancement of anti-tumor effect of plasmid DNA-carrying MUC1 by the adjuvanticity of FLT3L in mouse model. Immunopharmacology and Immunotoxicology 40:4, pages 353-357.
Read now
John J. Suschak, James A. Williams & Connie S. Schmaljohn. (2017) Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity. Human Vaccines & Immunotherapeutics 13:12, pages 2837-2848.
Read now

Articles from other publishers (178)

Chen Zhang, Zhao Zhao, Yi-Jun Jia, Peng-Qi Zhang, Yun Sun, Yong-Can Zhou, Gao-Xue Wang & Bin Zhu. (2023) Rationally Designed Self-Assembling Nanovaccines Elicit Robust Mucosal and Systemic Immunity against Rhabdovirus. ACS Applied Materials & Interfaces.
Crossref
Jeffrey M. Skolnik & Matthew P. Morrow. (2023) Vaccines for HPV-associated diseases. Molecular Aspects of Medicine 94, pages 101224.
Crossref
Sthefany Pagliari, Barbara Dema, Alexandra Sanchez-Martinez, Gerardo Montalvo Zurbia-Flores & Christine S. Rollier. (2023) DNA Vaccines: History, Molecular Mechanisms and Future Perspectives. Journal of Molecular Biology 435:23, pages 168297.
Crossref
Fahime Edalat, Fatemeh Hosseini Tabatabaie, Afagh Moattari, Arash Letafati, Jamal Sarvari & Seyed Younes Hosseini. (2023) Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform. Vacunas.
Crossref
Hongquan Qin, Jiali Chen, Katia Bouchekioua-Bouzaghou, Ya-Ming Meng, Jordi Bach Griera, Xue Jiang, Xiangzhan Kong, Minghui Wang, Qiuping Xu & Ping-Pui Wong. (2023) Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk. Journal of Translational Medicine 21:1.
Crossref
Manaf Al Matar, Aizi Nor Mazila Ramli, Osman Albarri & Choong Xin Yi. (2023) Insights into the Structural Complexities of SARS-CoV-2 for Therapeutic and Vaccine Development. Combinatorial Chemistry & High Throughput Screening 26:11, pages 1945-1959.
Crossref
Jennifer Soto, Chase Linsley, Yang Song, Binru Chen, Jun Fang, Josephine Neyyan, Raul Davila, Brandon Lee, Benjamin Wu & Song Li. (2023) Engineering Materials and Devices for the Prevention, Diagnosis, and Treatment of COVID-19 and Infectious Diseases. Nanomaterials 13:17, pages 2455.
Crossref
Marina Barrio-Calvo, Søren Vester Kofoed, Sofie Cens Holste, Anders Bundgård Sørensen, Nadia Viborg, Jens Vindahl Kringelum, Daniela Kleine-Kohlbrecher, Christian Skjødt Steenmans, Christian Bahne Thygesen, Birgitte Rønø & Stine Friis. (2023) Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine. Frontiers in Immunology 14.
Crossref
Hai Xu, Shanyuan Zhu, Roshini Govinden & Hafizah Y. Chenia. (2023) Multiple Vaccines and Strategies for Pandemic Preparedness of Avian Influenza Virus. Viruses 15:8, pages 1694.
Crossref
Tábata Almeida Silva, Rodrigo Barbosa Aguiar, Marcelo Mori, Gabriel Esquitini Machado, Barbara Hamaguchi, Marcelo Ferreira Marcondes Machado & Jane Zveiter Moraes. (2022) Potential of an anti-bevacizumab idiotype scFv DNA-based immunization to elicit VEGF-binding antibody response. Gene Therapy 30:7-8, pages 598-602.
Crossref
Zi‐xuan Qin, Chen‐yu Wang, Jiang‐shan Zhang, Zhang‐yi Wang, Yu Wei, Yu‐tao Li, Shi‐qi Dai, Franklin R Tay & Li‐na Niu. (2023) DNA‐Based Materials Inspired by Natural Extracellular DNA. Advanced Functional Materials 33:31.
Crossref
Simon Hawlina, Robert Zorec & Helena H. Chowdhury. (2023) Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer. Life 13:7, pages 1498.
Crossref
Priyanshi Goyal & Rishabha Malviya. (2023) Advancement in Polymer-based Carrier for DNA Vaccine. Current Pharmaceutical Design 29:26, pages 2062-2077.
Crossref
Long Huang, Yu Liu, Xinxin Zhang, Jie Xu, Lu Dai, Lishang Dai & Lehao Huang. (2023) Peroxiredoxin 1 of Procambarus clarkii govern immune responses during pathogen infection. Fish & Shellfish Immunology 138, pages 108828.
Crossref
Jianmei Guo, Lin Tang, Kelin Li, Qingxin Ma, Shuda Luo, Ruoyu Cheng & Chaoyong Liu. (2023) Application of Nanotechnology in Therapeutic Cancer Vaccines. Advanced NanoBiomed Research 3:7.
Crossref
Grant C Paulsen, Robert FrenckJrJr, Kay M Tomashek, Rodolfo M Alarcon, Elizabeth Hensel, Ashley Lowe, Rebecca L Brocato, Steve A Kwilas, Matthew D Josleyn & Jay W Hooper. (2023) Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: A Randomized, Controlled Phase 1 Study. The Journal of Infectious Diseases.
Crossref
Aanshi Pandya, Yesha Shah, Nirjari Kothari, Humzah Postwala, Aayushi Shah, Priyajeet Parekh & Mehul R. Chorawala. (2023) The future of cancer immunotherapy: DNA vaccines leading the way. Medical Oncology 40:7.
Crossref
Thibault Colombani, Thomas Haudebourg & Bruno Pitard. (2023) 704/DNA vaccines leverage cytoplasmic DNA stimulation to promote anti-HIV neutralizing antibody production in mice and strong immune response against alpha-fetoprotein in non-human primates. Molecular Therapy - Nucleic Acids 32, pages 743-757.
Crossref
Faizan Zarreen Simnani, Dibyangshee Singh, Paritosh Patel, Anmol Choudhury, Adrija Sinha, Aditya Nandi, Shailesh Kumar Samal, Suresh K. Verma & Pritam Kumar Panda. (2023) Nanocarrier vaccine therapeutics for global infectious and chronic diseases. Materials Today 66, pages 371-408.
Crossref
Haochen Wang, Junhua Xu & Lin Xiang. (2023) Microneedle‐Mediated Transcutaneous Immunization: Potential in Nucleic Acid Vaccination. Advanced Healthcare Materials.
Crossref
Chuan Wang, Yingqi Jin, Jiewen Wang, Kang Zheng, Aihua Lei, Chunxue Lu, Shuzhi Wang & Yimou Wu. (2023) Protective Immunity against Chlamydia psittaci Lung Infection Induced by a DNA Plasmid Vaccine Carrying CPSIT_p7 Gene Inhibits Dissemination in BALB/c Mice. International Journal of Molecular Sciences 24:8, pages 7013.
Crossref
Roghayyeh Baghban, Abdolmajid Ghasemian & Shirin Mahmoodi. (2023) Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19). Archives of Microbiology 205:4.
Crossref
Muhammad Nadeem Abbas, Mohamed Amine Jmel, Imen Mekki, Ingrid Dijkgraaf & Michail Kotsyfakis. (2023) Recent Advances in Tick Antigen Discovery and Anti-Tick Vaccine Development. International Journal of Molecular Sciences 24:5, pages 4969.
Crossref
Chao Chen, Xuhong Zhao, Zhigao An, Muhammad Jamil Ahmad, Kaifeng Niu, Xinxin Zhang, Pei Nie, Jiaomei Tang, Aixin Liang & Liguo Yang. (2023) Nasal immunization with AMH-INH-RFRP DNA vaccine for improving follicle development and fertility in buffaloes. Frontiers in Endocrinology 14.
Crossref
Carmen Ledesma-Feliciano, Ros Chapman, Jay W. Hooper, Kira Elma, Darin Zehrung, Miles B. Brennan & Erin K. Spiegel. (2023) Improved DNA Vaccine Delivery with Needle-Free Injection Systems. Vaccines 11:2, pages 280.
Crossref
Na Xie, Guobo Shen, Wei Gao, Zhao Huang, Canhua Huang & Li Fu. (2023) Neoantigens: promising targets for cancer therapy. Signal Transduction and Targeted Therapy 8:1.
Crossref
Elizaveta Starodubova, Ksenia Tuchynskaya, Yulia Kuzmenko, Anastasia Latanova, Vera Tutyaeva, Vadim Karpov & Galina Karganova. (2023) Activation of Early Proinflammatory Responses by TBEV NS1 Varies between the Strains of Various Subtypes. International Journal of Molecular Sciences 24:2, pages 1011.
Crossref
Reeshan ul Quraish, Tetsuyuki Hirahata, Afraz ul Quraish & Shahan ul Quraish. (2023) An Overview: Genetic Tumor Markers for Early Detection and Current Gene Therapy Strategies. Cancer Informatics 22, pages 117693512211507.
Crossref
Sunny Kumar, Malini Basu, Pratyasha Ghosh, Aafreen Ansari & Mrinal K. Ghosh. (2022) COVID‐19: Clinical status of vaccine development to date. British Journal of Clinical Pharmacology 89:1, pages 114-149.
Crossref
Samira Hossaini Alhashemi, Fatemeh Ahmadi & Ali Dehshahri. (2023) Lessons learned from COVID-19 pandemic: Vaccine platform is a key player. Process Biochemistry 124, pages 269-279.
Crossref
Hayeqa Shahwar Awan, Fatima Shahid, Almas Chaudhry & Amjad Ali. 2023. Omics approaches and technologies in COVID-19. Omics approaches and technologies in COVID-19 339 350 .
Rani S. Sellers & Keith Nelson. 2023. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology 335 396 .
Patric U. B. VogelPatric U. B. Vogel. 2023. COVID-19: Search for a vaccine. COVID-19: Search for a vaccine 29 34 .
Walter Gottlieb LandWalter Gottlieb Land. 2023. Damage-Associated Molecular Patterns in Human Diseases. Damage-Associated Molecular Patterns in Human Diseases 3 44 .
Xiang‐Yuan Fan, Xiao‐Can Xu, Ya‐Xue Wu, Xiao‐Ya Liu, Feng Yang & Yong‐Hong Hu. (2022) Evaluation of anti‐tick efficiency in rabbits induced by DNA vaccines encoding Haemaphysalis longicornis lipocalin homologue . Medical and Veterinary Entomology 36:4, pages 511-515.
Crossref
Juliana Santos Rosa Viegas, Maria Vitória Lopes Badra Bentley & Fabiana Testa Moura de Carvalho Vicentini. (2022) Challenges to perform an efficiently gene therapy adopting non-viral vectors: Melanoma landscape. Journal of Drug Delivery Science and Technology 78, pages 103964.
Crossref
William R. Hartman. (2022) An Executed Plan to Combat COVID-19 in the United States. Advances in Anesthesia 40:1, pages 45-62.
Crossref
Chao Chen, Zichao Zhou, Kaifeng Niu, Chao Du, Aixin Liang & Liguo Yang. (2022) Efficacy and Safety of Nasal Immunisation with Somatostatin DNA Vaccine for Growth Promotion in Fattening Pigs. Animals 12:22, pages 3072.
Crossref
Denis N. Kisakov, Lyubov A. Orlova, Сергей V. Sharabrin, Andrey P. Rudometov, Maria B. Borgoyakova, Ekaterina V. Starostina, Larisa I. Karpenko & Alexander A. Ilyichev. (2022) Delivery of a DNA vaccine encoding SARS-CoV-2 receptor-binding domain (RBD) by electroporation. Medical academic journal 2:2, pages 191-196.
Crossref
Lin Cheng, Xian Tang, Yun He, Bin Ju & Hui Wang. (2022) A Δ42PD1 fusion-expressing DNA vaccine elicits enhanced adaptive immune response to HIV-1: the key role of TLR4. Virology Journal 19:1.
Crossref
Md Nurul Huda & Md Nurunnabi. (2022) Potential Application of Exosomes in Vaccine Development and Delivery. Pharmaceutical Research 39:11, pages 2635-2671.
Crossref
Jenni Viivi Linnea Niemi, Aleksandr V. Sokolov & Helgi B. Schiöth. (2022) Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial Treatments. Cancers 14:20, pages 5163.
Crossref
Guanyu Zhao, Jiaqi Zhang, Wenchao Sun, Changzhan Xie, He Zhang, Yan Gao, Shubo Wen, Zhuo Ha, Fulong Nan, Xiangyu Zhu, Sheng Feng, Xinyu Cao, Ying Zhang, Yanzhu Zhu, Ningyi Jin & Huijun Lu. (2022) Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines in vivo. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Juan Wu, Zhidong Hu, Shui-Hua Lu & Xiao-Yong Fan. (2022) Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against Mycobacterium tuberculosis in mice. Frontiers in Microbiology 13.
Crossref
Cathy Ventura, Ângelo Luís, Christiane P. Soares, Aldo Venuti, Francesca Paolini, Luísa Pereira & Ângela Sousa. (2022) The Effectiveness of Therapeutic Vaccines for the Treatment of Cervical Intraepithelial Neoplasia 3: A Systematic Review and Meta-Analysis. Vaccines 10:9, pages 1560.
Crossref
Hiroki Hayashi, Jiao Sun, Yuka Yanagida, Takako Otera, Ritsuko Kubota-Koketsu, Tatsuo Shioda, Chikako Ono, Yoshiharu Matsuura, Hisashi Arase, Shota Yoshida, Ryo Nakamaru, Nan Ju, Ryoko Ide, Akiko Tenma, Sotaro Kawabata, Takako Ehara, Makoto Sakaguchi, Hideki Tomioka, Munehisa Shimamura, Sachiko Okamoto, Yasunori Amaishi, Hideto Chono, Junichi Mineno, Takao Komatsuno, Yoshimi Saito, Hiromi Rakugi, Ryuichi Morishita & Hironori Nakagami. (2022) Preclinical study of a DNA vaccine targeting SARS-CoV-2. Current Research in Translational Medicine 70:4, pages 103348.
Crossref
Jinze Dong, Yong Zhou, Juan Pu & Litao Liu. (2022) Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China. Life 12:9, pages 1326.
Crossref
Alexander Batista-Duharte, Fakhri Hassouneh, Pablo Alvarez-Heredia, Alejandra Pera & Rafael Solana. (2022) Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches. Pharmaceutics 14:8, pages 1721.
Crossref
Isabel Acosta-Coley, Leonor Cervantes-Ceballos, Lesly Tejeda-Benítez, Lucellys Sierra-Márquez, María Cabarcas-Montalvo, María García-Espiñeira, Wilfrido Coronell-Rodríguez & Bárbara Arroyo-Salgado. (2022) Vaccines platforms and COVID-19: what you need to know. Tropical Diseases, Travel Medicine and Vaccines 8:1.
Crossref
María Lilia Nicolás-Morales, Arianna Luisa-Sanjuan, Mayralina Gutiérrez-Torres, Amalia Vences-Velázquez, Carlos Ortuño-Pineda, Mónica Espinoza-Rojo, Napoleón Navarro-Tito & Karen Cortés-Sarabia. (2022) Peptide-Based Vaccines in Clinical Phases and New Potential Therapeutic Targets as a New Approach for Breast Cancer: A Review. Vaccines 10:8, pages 1249.
Crossref
Dmitriy V. Volokhov, Vyacheslav Furtak, Cynthia Allen, Gayle Pulle, Michelle D. Zajac, Yotam Levin, Efrat Kochba & Susan M. Moore. (2022) Robust humoral immune response against rabies virus in rabbits and guinea pigs immunized with plasmid DNA vectors encoding rabies virus glycoproteins – An approach to the production of polyclonal antibody reagents. Molecular and Cellular Probes 64, pages 101833.
Crossref
Warren R. J. de Moor, Guy L. Regnard, Edward P. Rybicki & Anna-Lise Williamson. (2022) Characterization of a dynamic self-replicating mammalian expression vector based on the circular ssDNA genome of beak and feather disease virus. Journal of General Virology 103:5.
Crossref
Wenjing Liu, Jing Xing, Xiaoqian Tang, Xiuzhen Sheng, Heng Chi & Wenbin Zhan. (2022) Characterization of Co-Stimulatory Ligand CD80/86 and Its Effect as a Molecular Adjuvant on DNA Vaccine Against Vibrio anguillarum in Flounder (Paralichthys olivaceus). Frontiers in Immunology 13.
Crossref
ZhiHua QIU, XiaJun HU, YanZhao ZHOU, HaiLang WU, JiaYu ZHENG, YingXuan WANG & YuHua LIAO. (2022) Progress and prospects of therapeutic vaccines for cardiovascular diseases. SCIENTIA SINICA Vitae 52:5, pages 781-794.
Crossref
Xiuhong Wu, Yuanjia Liu, Liguo Gao, Zhuanqiang Yan, Qiqi Zhao, Feng Chen, Qingmei Xie & Xinheng Zhang. (2022) Development and Application of a Reverse-Transcription Recombinase-Aided Amplification Assay for Porcine Epidemic Diarrhea Virus. Viruses 14:3, pages 591.
Crossref
Maria Karoliny da Silva Torres, Carlos David Araújo Bichara, Maria de Nazaré do Socorro de Almeida, Mariana Cayres Vallinoto, Maria Alice Freitas Queiroz, Izaura Maria Vieira Cayres Vallinoto, Eduardo José Melo dos Santos, Carlos Alberto Marques de Carvalho & Antonio Carlos R. Vallinoto. (2022) The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic. Frontiers in Microbiology 13.
Crossref
Na Young Kim, Won Rak Son, Min Hoon Lee, Hong Seok Choi, Jun Young Choi, Young Jo Song, Chi Ho Yu, Dong Hyun Song, Gyeung Haeng Hur, Seong Tae Jeong, Sung Youl Hong, Young Kee Shin & Sungho Shin. (2022) A multipathogen DNA vaccine elicits protective immune responses against two class A bioterrorism agents, anthrax and botulism. Applied Microbiology and Biotechnology 106:4, pages 1531-1542.
Crossref
Stephane Koda, Xing-Quan Zhu, Kui-Yang Zheng & Chao Yan. (2022) Molecular Mechanisms of Clonorchis sinensis-Host Interactions and Implications for Vaccine Development. Frontiers in Cell and Developmental Biology 9.
Crossref
Abhijeet Nayak. 2022. Microbial Engineering for Therapeutics. Microbial Engineering for Therapeutics 163 200 .
Diana C. DeLucia & John K. Lee. 2022. Cancer Immunotherapies. Cancer Immunotherapies 1 48 .
Sapna Sharma & Kai Dallmeier. 2022. Vaccine Design. Vaccine Design 283 294 .
Aditi Sharma & K. K. Sharma. (2021) Overview on Covid-19 Vaccine - A Short Review. Journal of Evolution of Medical and Dental Sciences 10:45, pages 4032-4036.
Crossref
Hong-Chao Sun, Jing Huang, Yuan Fu, Li-Li Hao, Xin Liu & Tuan-Yuan Shi. (2021) Enhancing Immune Responses to a DNA Vaccine Encoding Toxoplasma gondii GRA7 Using Calcium Phosphate Nanoparticles as an Adjuvant. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Xue-Liang Peng, Ji-Si-Yu Cheng, Hai-Lun Gong, Meng-Di Yuan, Xiao-Hong Zhao, Zibiao Li & Dai-Xu Wei. (2021) Advances in the design and development of SARS-CoV-2 vaccines. Military Medical Research 8:1.
Crossref
Mandeep Garg, Muniraju Maralakunte, Yashwant Kumar, Harish Bhujade, Inder Paul Sehgal, Vikas Suri & Suruchi Garg. (2021) Vaccine-induced immune responses against SARS-CoV-2 infections. Exploration of Immunology, pages 356-373.
Crossref
Chenlu Liu, Xianling Cong, Yuqian Wang, Qianqian Guo, Yu Xie, Fei Geng, Jie Guo, Ling Dong, Yi Zhou, Hui Wu, Bin Yu, Jiaxin Wu, Haihong Zhang, Xianghui Yu & Wei Kong. (2021) Fast DNA Vaccination Strategy Elicits a Stronger Immune Response Dependent on CD8+CD11c+ Cell Accumulation. Frontiers in Oncology 11.
Crossref
Mojtaba Taheri, Mehran Nemattalab, Mohammad Mahjoob, Elham Hasan-alizadeh, Nina Zamani, Iraj Nikokar, Mehdi Evazalipour, Bahram Soltani Tehrani & Mohammad Shenagari. (2021) Toward a universal influenza virus vaccine: Some cytokines may fulfill the request. Cytokine 148, pages 155703.
Crossref
Chao-Hung Chen, Guan-Ming Ke, Pi-Chen Lin & Kun-Der Lin. (2021) Therapeutic DNA vaccine encoding CEMIP (KIAA1199) ameliorates kidney fibrosis in obesity through inhibiting the Wnt/β-catenin pathway. Biochimica et Biophysica Acta (BBA) - General Subjects 1865:12, pages 130019.
Crossref
Alfredo Addeo, Alex Friedlaender, Elisa Giovannetti, Alessandro Russo, Diego de Miguel-Perez, Oscar Arrieta, Andres F. Cardona & Christian Rolfo. (2021) A New Generation of Vaccines in the Age of Immunotherapy. Current Oncology Reports 23:12.
Crossref
Uday S. Kumar, Rayhaneh Afjei, Katherine Ferrara, Tarik F. Massoud & Ramasamy Paulmurugan. (2021) Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle. ACS Nano 15:11, pages 17582-17601.
Crossref
Yushi Isozaki, Kanta Tsumoto & Masahiro Tomita. (2021) Class-Switching of B Lymphocytes by DNA and Cell Immunization for Stereospecific Monoclonal Antibodies against Native GPCR. Immuno 1:4, pages 432-441.
Crossref
Efthymios P Tsounis, Athanasia Mouzaki & Christos Triantos. (2021) Nucleic acid vaccines: A taboo broken and prospect for a hepatitis B virus cure. World Journal of Gastroenterology 27:41, pages 7005-7013.
Crossref
Huanyou Sun, Juan Li, Wenwen Hu, Yinan Yan, Zengli Guo, Zichun Zhang, Yuxin Chen, Xuefan Yao, Ling Teng, Xinyuan Wang, Liantao Li, Dafei Chai, Junnian Zheng & Gang Wang. (2021) Co-immunizing with HMGB1 enhances anti-tumor immunity of B7H3 vaccine in renal carcinoma. Molecular Immunology 139, pages 184-192.
Crossref
Dalinda Eusébio, Ana R. Neves, Diana Costa, Swati Biswas, Gilberto Alves, Zhengrong Cui & Ângela Sousa. (2021) Methods to improve the immunogenicity of plasmid DNA vaccines. Drug Discovery Today 26:11, pages 2575-2592.
Crossref
Ada Maria de Barcelos Alves, Silvia Beatriz Boscardin & Annie Elong Ngono. (2021) Editorial: DNA Vaccines. Frontiers in Medical Technology 3.
Crossref
Zehua Zhou, Xinyu Zhang, Qianqian Li, Lili Fu, Meiyu Wang, Shuo Liu, Jiajing Wu, Jianhui Nie, Li Zhang, Chenyan Zhao, Fei Jiang, Yimeng An, Bin Yu, Haifa Zheng, Youchun Wang, Aihua Zhao & Weijin Huang. (2021) Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19. Vaccine 39:41, pages 6050-6056.
Crossref
Xiaoyue Yang, Jiansheng Fan, Yue Wu, Zhiming Ma, Jin Huang, Ying Zhang, Zhan Zhou, Fan Mo, Xuerong Liu, Hong Yuan, Yingchun Xu, Liqiang Pan & Shuqing Chen. (2021) Synthetic multiepitope neoantigen DNA vaccine for personalized cancer immunotherapy. Nanomedicine: Nanotechnology, Biology and Medicine 37, pages 102443.
Crossref
Hadis Fathizadeh, Saman Afshar, Mahmood Reza Masoudi, Pourya Gholizadeh, Mohammad Asgharzadeh, Khudaverdi Ganbarov, Şükran Köse, Mehdi Yousefi & Hossein Samadi Kafil. (2021) SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review. International Journal of Biological Macromolecules 188, pages 740-750.
Crossref
Dafei Chai, Zichun Zhang, Nan Jiang, Jiage Ding, Dong Qiu, Shang Yuchen Shi, Gang Wang, Lin Fang, Huizhong Li, Hui Tian, Jie Yang, Qing Zhang & Junnian Zheng. (2021) Co‐immunization with L‐Myc enhances CD8 + or CD103 + DCs mediated tumor‐specific multi‐functional CD8 + T cell responses . Cancer Science 112:9, pages 3469-3483.
Crossref
Pranjal Somvanshi & Shefali Khisty. (2021) Peptide-based DNA delivery system. Medicine in Novel Technology and Devices 11, pages 100091.
Crossref
Guangna Liu, Motao Zhu, Xiao Zhao & Guangjun Nie. (2021) Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity. Advanced Drug Delivery Reviews 176, pages 113889.
Crossref
Dilhan J. Perera & Momar Ndao. (2021) Promising Technologies in the Field of Helminth Vaccines. Frontiers in Immunology 12.
Crossref
Kate Guilfoyle, Diane Major, Sarah Skeldon, Heather James, Jeanette L. Tingstedt, Charlotta Polacek, Ria Lassauniére, Othmar G. Engelhardt & Anders Fomsgaard. (2021) Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model. Vaccine 39:34, pages 4903-4913.
Crossref
Mira Hoteit, Zeina Oneissi, Ranim Reda, Fadi Wakim, Amar Zaidan, Mohammad Farran, Eli Abi‑Khalil & Mirvat El‑Sibai. (2021) Cancer immunotherapy: A comprehensive appraisal of its modes of application (Review). Oncology Letters 22:3.
Crossref
Yousef Rasmi, Kouass Saloua, Mahdieh Nemati & Jane Choi. (2021) Recent Progress in Nanotechnology for COVID-19 Prevention, Diagnostics and Treatment. Nanomaterials 11:7, pages 1788.
Crossref
Yi-Pin Chen, Chu-Chi Lin, Yu-Xin Xie, Chia-Yuan Chen & J. Timothy Qiu. (2021) Enhancing immunogenicity of HPV16 E7 DNA vaccine by conjugating codon-optimized GM-CSF to HPV16 E7 DNA. Taiwanese Journal of Obstetrics and Gynecology 60:4, pages 700-705.
Crossref
Hajar Ziaei Hezarjaribi, Masoud Soosaraei, Mahdi Fakhar, Javad Akhtari, Alireza Rafiei & Oghol Niaz Jorjani. (2021) Preparation and Characterization of A Nanoliposomal Vaccine of pcLACK Candidate Against Cutaneous Leishmaniasis. Infectious Disorders - Drug Targets 21:4, pages 527-533.
Crossref
Jeffrey B. Ulmer & Margaret A. Liu. (2021) Path to Success and Future Impact of Nucleic Acid Vaccines: DNA and mRNA. Molecular Frontiers Journal 05:01n02, pages 38-57.
Crossref
Hylemariam Mihiretie Mengist, Arnaud John Kombe Kombe, Daniel Mekonnen, Abtie Abebaw, Melese Getachew & Tengchuan Jin. (2021) Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity. Seminars in Immunology 55, pages 101533.
Crossref
Furong Qin, Fan Xia, Hongli Chen, Bomiao Cui, Yun Feng, Ping Zhang, Jiao Chen & Min Luo. (2021) A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications. Frontiers in Cell and Developmental Biology 9.
Crossref
Takashi Imai. (2021) Single Amino Acid Deletion at N-Terminus of the Target Antigen in DNA Vaccine Induces Altered CD8+ T Cell Responses against Tumor Antigen. Vaccines 9:6, pages 540.
Crossref
Shuaikai Ren, Liang Guo, Chunxin Wang, Jiaxi Ru, Yunqi Yang, Yan Wang, Changjiao Sun, Haixin Cui, Xiang Zhao & Huichen Guo. (2021) Construction of an Effective Delivery System for DNA Vaccines Using Biodegradable Polylactic Acid Based Microspheres. Journal of Biomedical Nanotechnology 17:5, pages 971-980.
Crossref
Mai H.S. Mohammad. (2021) Immune response scenario and vaccine development for SARS-CoV-2 infection. International Immunopharmacology 94, pages 107439.
Crossref
Duško Lainšček, Tina Fink, Vida Forstnerič, Iva Hafner-Bratkovič, Sara Orehek, Žiga Strmšek, Mateja Manček-Keber, Peter Pečan, Hana Esih, Špela Malenšek, Jana Aupič, Petra Dekleva, Tjaša Plaper, Sara Vidmar, Lucija Kadunc, Mojca Benčina, Neža Omersa, Gregor Anderluh, Florence Pojer, Kelvin Lau, David Hacker, Bruno E. Correia, David Peterhoff, Ralf Wagner, Valter Bergant, Alexander Herrmann, Andreas Pichlmair & Roman Jerala. (2021) A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response. Vaccines 9:5, pages 431.
Crossref
Zhi-Peng Yan, Ming Yang & Ching-Lung Lai. (2021) COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials. Pharmaceuticals 14:5, pages 406.
Crossref
Ada Maria Barcelos Alves, Simone Morais Costa & Paolla Beatriz Almeida Pinto. (2021) Dengue Virus and Vaccines: How Can DNA Immunization Contribute to This Challenge?. Frontiers in Medical Technology 3.
Crossref
Chenjian Gu, Lijun Ming, Shuai Tao, Mengjun Luo, Huimin Guo, Youhua Xie, Jing Liu & Zhongliang Shen. (2021) Transfected DNA is targeted by STING-mediated restriction. Biochemical and Biophysical Research Communications 549, pages 207-213.
Crossref
William Ho, Mingzhu Gao, Fengqiao Li, Zhongyu Li, Xue‐Qing Zhang & Xiaoyang Xu. (2021) Next‐Generation Vaccines: Nanoparticle‐Mediated DNA and mRNA Delivery. Advanced Healthcare Materials 10:8.
Crossref
Davis W. Crews, Jenna A. Dombroski & Michael R. King. (2021) Prophylactic Cancer Vaccines Engineered to Elicit Specific Adaptive Immune Response. Frontiers in Oncology 11.
Crossref
Marwan ElBagoury, Mahmoud M. Tolba, Hebatallah A. Nasser, Abdul Jabbar, Ahmed M. Elagouz, Yahia Aktham & Amy Hutchinson. (2021) The find of COVID-19 vaccine: Challenges and opportunities. Journal of Infection and Public Health 14:3, pages 389-416.
Crossref
Lanxiang Huang, Yuan Rong, Qin Pan, Kezhen Yi, Xuan Tang, Qian Zhang, Wei Wang, Jianyuan Wu & Fubing Wang. (2021) SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies. Asian Journal of Pharmaceutical Sciences 16:2, pages 136-146.
Crossref
Deborah Pushparajah, Salma Jimenez, Shirley Wong, Hibah Alattas, Nafiseh Nafissi & Roderick A. Slavcev. (2021) Advances in gene-based vaccine platforms to address the COVID-19 pandemic. Advanced Drug Delivery Reviews 170, pages 113-141.
Crossref
Saba Davoodi, Azam Bolhassani & Fatemeh Namazi. (2021) In vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate. Biotechnology Letters 43:3, pages 547-559.
Crossref
Judit Giménez-Roig, Estela Núñez-Manchón, Ramon Alemany, Eneko Villanueva & Cristina Fillat. (2021) Codon Usage and Adenovirus Fitness: Implications for Vaccine Development. Frontiers in Microbiology 12.
Crossref
Rebecca L. Brocato, Steven A. Kwilas, Matthew D. Josleyn, Simon Long, Xiankun Zeng, Casey C. Perley, Lucia M. Principe, Brandon Somerville, Melanie V. Cohen & Jay W. Hooper. (2021) Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines. Vaccine 39:7, pages 1101-1110.
Crossref
Marcelle Moura Silveira, Gustavo Marçal Schmidt Garcia Moreira & Marcelo Mendonça. (2021) DNA vaccines against COVID-19: Perspectives and challenges. Life Sciences 267, pages 118919.
Crossref
Xiao Tan, Justin H. Letendre, James J. Collins & Wilson W. Wong. (2021) Synthetic biology in the clinic: engineering vaccines, diagnostics, and therapeutics. Cell 184:4, pages 881-898.
Crossref
Kyung Soo Park, Xiaoqi Sun, Marisa E. Aikins & James J. Moon. (2021) Non-viral COVID-19 vaccine delivery systems. Advanced Drug Delivery Reviews 169, pages 137-151.
Crossref
Shintaro Fumoto, Tsuyoshi Yamamoto, Kazuya Okami, Yuina Maemura, Chisato Terada, Asako Yamayoshi & Koyo Nishida. (2021) Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs. Pharmaceutics 13:2, pages 159.
Crossref
Anu Sharma, RaviPrakash Sharma, Rimplejeet Kaur, Ria Sharma & Surjit Singh. (2021) A comprehensive insight on the COVID-19 vaccine candidates. Journal of Family Medicine and Primary Care 10:7, pages 2457.
Crossref
Zuzana Strizova, Jitka Smetanova, Jirina Bartunkova & Tomas Milota. (2021) Principles and Challenges in anti-COVID-19 Vaccine Development. International Archives of Allergy and Immunology 182:4, pages 339-349.
Crossref
Radha Yadav & Lalita Chopra. (2021) Comparative analysis of candidate vaccines to prevent covid 19 pandemic. E3S Web of Conferences 309, pages 01038.
Crossref
Abdou Nagy & Bader Alhatlani. (2021) An overview of current COVID-19 vaccine platforms. Computational and Structural Biotechnology Journal 19, pages 2508-2517.
Crossref
Fataneh Fatemi, Zahra Hassani Nejad & Seyed Ehsan Ranaei Siadat. 2021. COVID-19. COVID-19 149 185 .
Lidia Tarone, Paolo Buracco, Federica Cavallo & Federica Riccardo. 2021. Electroporation in Veterinary Oncology Practice. Electroporation in Veterinary Oncology Practice 277 304 .
Sara Hemmati, Mahsa Keshavarz-Fathi, Sepideh Razi & Nima Rezaei. 2021. Cancer Immunology. Cancer Immunology 129 142 .
Ailar Sabbaghi & Amir Ghaemi. 2021. DNA Vaccines. DNA Vaccines 87 112 .
Zhiwei Li, Zhiqian Ma, Yang Li, Sheng Gao & Shuqi Xiao. (2020) Porcine epidemic diarrhea virus: Molecular mechanisms of attenuation and vaccines. Microbial Pathogenesis 149, pages 104553.
Crossref
Nina Marí G.P. de Queiroz, Fabio V. Marinho, Marcelo A. Chagas, Luciana C.C. Leite, E. Jane Homan, Mariana T.Q. de Magalhães & Sergio C. Oliveira. (2020) Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system. Microbes and Infection 22:10, pages 515-524.
Crossref
Youssof Sefidi-Heris, Abolfazl Jahangiri, Ahad Mokhtarzadeh, Mohammad-Ali Shahbazi, Saeed Khalili, Behzad Baradaran, Jafar Mosafer, Amir Baghbanzadeh, Maryam Hejazi, Mahmoud Hashemzaei, Michael R. Hamblin & Hélder A. Santos. (2020) Recent progress in the design of DNA vaccines against tuberculosis. Drug Discovery Today 25:11, pages 1971-1987.
Crossref
Fatima Laher, Linda-Gail Bekker, Nigel Garrett, Erica M. Lazarus & Glenda E. Gray. (2020) Review of preventative HIV vaccine clinical trials in South Africa. Archives of Virology 165:11, pages 2439-2452.
Crossref
Young Hun Chung, Veronique Beiss, Steven N. Fiering & Nicole F. Steinmetz. (2020) COVID-19 Vaccine Frontrunners and Their Nanotechnology Design. ACS Nano 14:10, pages 12522-12537.
Crossref
Masoud Foroutan, Mohammad Barati & Fatemeh Ghaffarifar. (2020) Enhancing immune responses by a novel multi-epitope ROP8 DNA vaccine plus interleukin-12 plasmid as a genetic adjuvant against acute Toxoplasma gondii infection in BALB/c mice. Microbial Pathogenesis 147, pages 104435.
Crossref
Neeraj Kumar, Damini Sood & Ramesh Chandra. (2020) Design and optimization of a subunit vaccine targeting COVID-19 molecular shreds using an immunoinformatics framework. RSC Advances 10:59, pages 35856-35872.
Crossref
Giuseppe Lofano, Corey P. Mallett, Sylvie Bertholet & Derek T. O’Hagan. (2020) Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines. npj Vaccines 5:1.
Crossref
E. G. Bogomolova, P. M. Kopeykin & A. A. Tagaev. (2020) Genetic engineering approaches to the development of modern therapeutics. Medical academic journal 20:3, pages 49-60.
Crossref
Maria Trovato, Rossella Sartorius, Luciana D’Apice, Roberta Manco & Piergiuseppe De Berardinis. (2020) Viral Emerging Diseases: Challenges in Developing Vaccination Strategies. Frontiers in Immunology 11.
Crossref
Satish Chandra Pandey, Veni Pande, Diksha Sati, Shobha Upreti & Mukesh Samant. (2020) Vaccination strategies to combat novel corona virus SARS-CoV-2. Life Sciences 256, pages 117956.
Crossref
Emanuele Sasso, Anna Morena D’Alise, Nicola Zambrano, Elisa Scarselli, Antonella Folgori & Alfredo Nicosia. (2020) New viral vectors for infectious diseases and cancer. Seminars in Immunology 50, pages 101430.
Crossref
Mirja Niskanen, Henna Myllymäki & Mika Rämet. (2020) DNA vaccination with the Mycobacterium marinum MMAR_4110 antigen inhibits reactivation of a latent mycobacterial infection in the adult Zebrafish. Vaccine 38:35, pages 5685-5694.
Crossref
Ji Won Han, Pil Soo Sung, Seon-Hui Hong, Hoyoung Lee, June Young Koh, Hyojin Lee, Scott White, Joel N. Maslow, David B. Weiner, Su-Hyung Park, Moonsup Jeong, Jeong Heo, Sang Hoon Ahn & Eui-Cheol Shin. (2020) IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses. Journal of Hepatology 73:1, pages 72-83.
Crossref
Anna K. Blakney, Yunqing Zhu, Paul F. McKayClément R. BoutonJonathan Yeow, Jiaqing TangKai HuKarnyart SamnuanChristopher L. Grigsby, Robin J. ShattockMolly M. Stevens. (2020) Big Is Beautiful: Enhanced saRNA Delivery and Immunogenicity by a Higher Molecular Weight, Bioreducible, Cationic Polymer. ACS Nano 14:5, pages 5711-5727.
Crossref
Sayeh Ezzikouri, Mohammad Enamul Hoque Kayesh, Soumaya Benjelloun, Michinori Kohara & Kyoko Tsukiyama-Kohara. (2020) Targeting Host Innate and Adaptive Immunity to Achieve the Functional Cure of Chronic Hepatitis B. Vaccines 8:2, pages 216.
Crossref
Daniela Calina, Anca Docea, Demetrios Petrakis, Alex Egorov, Aydar Ishmukhametov, Alexsandr Gabibov, Michael Shtilman, Ronald Kostoff, Félix Carvalho, Marco Vinceti, Demetrios Spandidos & Aristidis Tsatsakis. (2020) Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review). International Journal of Molecular Medicine 46:1, pages 3-16.
Crossref
Rachid Bouzid, Maikel Peppelenbosch & Sonja I. Buschow. (2020) Opportunities for Conventional and In Situ Cancer Vaccine Strategies and Combination with Immunotherapy for Gastrointestinal Cancers, A Review. Cancers 12:5, pages 1121.
Crossref
Ghazaleh Laliani, Shokufeh Ghasemian Sorboni, Roya Lari, Atieh Yaghoubi, Saman Soleimanpour, Majid Khazaei, Seyed Mahdi Hasanian & Amir Avan. (2020) Bacteria and cancer: Different sides of the same coin. Life Sciences 246, pages 117398.
Crossref
Masoud Foroutan, Fatemeh Ghaffarifar, Zohreh Sharifi & Abdolhosein Dalimi. (2020) Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice. Comparative Immunology, Microbiology and Infectious Diseases 69, pages 101413.
Crossref
Yann Thierry Le Guen, Tony Le Gall, Patrick Midoux, Philippe Guégan, Serge Braun & Tristan Montier. (2020) Gene transfer to skeletal muscle using hydrodynamic limb vein injection: current applications, hurdles and possible optimizations. The Journal of Gene Medicine 22:2.
Crossref
Neeraj Kumar, Damini Sood, Neera Sharma & Ramesh Chandra. (2019) Multiepitope Subunit Vaccine to Evoke Immune Response against Acute Encephalitis. Journal of Chemical Information and Modeling 60:1, pages 421-433.
Crossref
Daniel C. Carter, Brenda Wright, W. Gray Jerome, John P. Rose & Ellen Wilson. (2020) A Unique Protein Self-Assembling Nanoparticle with Significant Advantages in Vaccine Development and Production. Journal of Nanomaterials 2020, pages 1-10.
Crossref
Xingye Yan, Mo Zhou, Shuang Yu, Zheng Jin & Kai Zhao. (2020) An overview of biodegradable nanomaterials and applications in vaccines. Vaccine 38:5, pages 1096-1104.
Crossref
Darrell J. Irvine, Aereas Aung & Murillo Silva. (2020) Controlling timing and location in vaccines. Advanced Drug Delivery Reviews 158, pages 91-115.
Crossref
T. Müller & C. M. Freuling. 2020. Rabies and Rabies Vaccines. Rabies and Rabies Vaccines 45 70 .
Hao Song, Yannan Yang, Jie Tang, Zhengying Gu, Yue Wang, Min Zhang & Chengzhong Yu. (2019) DNA Vaccine Mediated by Rambutan‐Like Mesoporous Silica Nanoparticles. Advanced Therapeutics 3:1.
Crossref
Alessandra Lopes, Gaëlle Vandermeulen & Véronique Préat. (2019) Cancer DNA vaccines: current preclinical and clinical developments and future perspectives. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Patrick Tjok Joe, Ioanna Christopoulou, Lien van Hoecke, Bert Schepens, Tine Ysenbaert, Carlo Heirman, Kris Thielemans, Xavier Saelens & Joeri L. Aerts. (2019) Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice. Journal of Translational Medicine 17:1.
Crossref
Mariane Melo, Ely Porter, Yuan Zhang, Murillo Silva, Na Li, Brian Dobosh, Alessia Liguori, Pat Skog, Elise Landais, Sergey Menis, Devin Sok, David Nemazee, William R. Schief, Ron Weiss & Darrell J. Irvine. (2019) Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles. Molecular Therapy 27:12, pages 2080-2090.
Crossref
Tayebeh Rezaei, Saeed Khalili, Behzad Baradaran, Jafar Mosafer, Sarah Rezaei, Ahad Mokhtarzadeh & Miguel de la Guardia. (2019) Recent advances on HIV DNA vaccines development: Stepwise improvements to clinical trials. Journal of Controlled Release 316, pages 116-137.
Crossref
Zhidong Hu, Weimin Jiang, Ling Gu, Dan Qiao, Tsugumine Shu, Douglas B. Lowrie, Shui-Hua Lu & Xiao-Yong Fan. (2019) Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines. Journal of Molecular Medicine 97:12, pages 1685-1694.
Crossref
Ana M. Almeida, João A. Queiroz, Fani Sousa & Ângela Sousa. (2019) Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins. Drug Discovery Today 24:10, pages 2044-2057.
Crossref
Payam Ghasemi-Dehkordi, Abbas Doosti & Mohammad-Saeid Jami. (2019) The concurrent effects of azurin and Mammaglobin-A genes in inhibition of breast cancer progression and immune system stimulation in cancerous BALB/c mice. 3 Biotech 9:7.
Crossref
Weiqi Wang, Madiha Saeed, Yao Zhou, Lili Yang, Dangge Wang & Haijun Yu. (2019) Non‐viral gene delivery for cancer immunotherapy. The Journal of Gene Medicine 21:7.
Crossref
A. A. Goryaev, M. V. Savkina, Yu. I. Obukhov, V. A. Merkulov & Yu. V. Olefir. (2019) DNA and RNA Vaccines: Current Status, Quality Requirements and Specific Aspects of Preclinical Studies. BIOpreparations. Prevention, Diagnosis, Treatment 19:2, pages 72-80.
Crossref
Jean-Daniel Lelièvre. (2019) Les vaccins de demain. Revue Francophone des Laboratoires 2019:512, pages 52-63.
Crossref
Sultan Gulce-Iz & Pelin Saglam-Metiner. 2019. Immune Response Activation and Immunomodulation. Immune Response Activation and Immunomodulation.
Jie Chen, Kui Wang, Jiayan Wu, Huayu Tian & Xuesi Chen. (2018) Polycations for Gene Delivery: Dilemmas and Solutions. Bioconjugate Chemistry 30:2, pages 338-349.
Crossref
Dafei Chai, Hongjian Shan, Gang Wang, Qing Zhang, Huizhong Li, Lin Fang, Jingyuan Song, Nianli Liu, Qian Zhang, Hong Yao & Junnian Zheng. (2019) Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8+ T-cell Responses. Molecular Cancer Therapeutics 18:2, pages 323-334.
Crossref
Mauricio A. MartinsGeorg F. BischofYoung C. ShinWilliam A. LauerLucas Gonzalez-NietoDavid I. WatkinsEva G. RakaszJeffrey D. Lifson & Ronald C. Desrosiers. (2019) Vaccine protection against SIVmac239 acquisition. Proceedings of the National Academy of Sciences 116:5, pages 1739-1744.
Crossref
Nevena Arsenović-Ranin. (2019) New vaccines on the horizon. Arhiv za farmaciju 69:6, pages 385-405.
Crossref
Luis A. Ureña-Búrquez, Aurora García-Rendón, Sarai Rochín-Wong & Armando Tejeda-Mansir. (2019) Preparation and characterization of a nanovaccine of pVAX1-NH36 for leishmaniasis. Fuel 235, pages 1077-1082.
Crossref
Roberto Ruiu, Valeria Rolih, Elisabetta Bolli, Giuseppina Barutello, Federica Riccardo, Elena Quaglino, Irene Fiore Merighi, Federica Pericle, Gaetano Donofrio, Federica Cavallo & Laura Conti. (2018) Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter. Cancer Immunology, Immunotherapy 68:1, pages 131-141.
Crossref
Sergio Rosales-Mendoza & Omar González-OrtegaSergio Rosales-Mendoza & Omar González-Ortega. 2019. Nanovaccines. Nanovaccines 319 336 .
María Elena Escobar-Ospina & Jonatan Gómez. 2019. Global Virology III: Virology in the 21st Century. Global Virology III: Virology in the 21st Century 149 305 .
Jihui Lee, Shreedevi Arun Kumar, Yong Yu Jhan & Corey J. Bishop. (2018) Engineering DNA vaccines against infectious diseases. Acta Biomaterialia 80, pages 31-47.
Crossref
Leo Yi Yang Lee, Leonard Izzard & Aeron C. Hurt. (2018) A Review of DNA Vaccines Against Influenza. Frontiers in Immunology 9.
Crossref
Zhong-Yuan Li, Jing Lu, Nian-Zhang Zhang, Jia Chen & Xing-Quan Zhu. (2018) Immune Responses Induced by HSP60 DNA Vaccine against Toxoplasma gondii Infection in Kunming Mice. The Korean Journal of Parasitology 56:3, pages 237-245.
Crossref
Jingbo Zhai, Qiubo Wang, Yunfeng Gao, Ran Zhang, Shengjun Li, Bing Wei, Yong You, Xun Sun & Changlong Lu. (2018) The mechanisms of Ag85A DNA vaccine activates RNA sensors through new signal transduction. International Immunopharmacology 59, pages 1-11.
Crossref
A. A. Latanova, S. Petkov, A. Kilpelainen, J. Jansons, O. E. Latyshev, Y. V. Kuzmenko, J. Hinkula, M. A. Abakumov, V. T. Valuev-Elliston, M. Gomelsky, V. L. Karpov, F. Chiodi, B. Wahren, D. Y. Logunov, E. S. Starodubova & M. G. Isaguliants. (2018) Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity. Scientific Reports 8:1.
Crossref
C. Liu, Y. Xie, B. Sun, F. Geng, F. Zhang, Q. Guo, H. Wu, B. Yu, J. Wu, X. Yu, W. Kong & H. Zhang. (2018) MUC1- and Survivin-based DNA Vaccine Combining Immunoadjuvants CpG and interleukin-2 in a Bicistronic Expression Plasmid Generates Specific Immune Responses and Antitumour Effects in a Murine Colorectal Carcinoma Model. Scandinavian Journal of Immunology 87:2, pages 63-72.
Crossref
Thomas Eden, Stephan Menzel, Janusz Wesolowski, Philine Bergmann, Marion Nissen, Gudrun Dubberke, Fabienne Seyfried, Birte Albrecht, Friedrich Haag & Friedrich Koch-Nolte. (2018) A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation. Frontiers in Immunology 8.
Crossref
Ingrid Karlsson, Marie Borggren, Maiken Worsøe Rosenstierne, Ramona Trebbien, James A. Williams, Enric Vidal, Júlia Vergara-Alert, David Solanes Foz, Ayub Darji, Marta Sisteré-Oró, Joaquim Segalés, Jens Nielsen & Anders Fomsgaard. (2018) Protective effect of a polyvalent influenza DNA vaccine in pigs. Veterinary Immunology and Immunopathology 195, pages 25-32.
Crossref
Guillermo Galvez-Romero, Mónica Salas-Rojas, Ericka N. Pompa-Mera, Karina Chávez-Rueda & Álvaro Aguilar-Setién. (2018) Addition of C3d-P28 adjuvant to a rabies DNA vaccine encoding the G5 linear epitope enhances the humoral immune response and confers protection. Vaccine 36:2, pages 292-298.
Crossref
Rabia Cakir-Koc & Burak Özdemir. 2018. The Microbiology of Central Nervous System Infections. The Microbiology of Central Nervous System Infections 305 317 .
Hari Pujar & Mats Lundgren. 2018. Biopharmaceutical Processing. Biopharmaceutical Processing 877 898 .
TOMOKAZU TAKANO. (2017) Application of molecular biology for the development of vaccines against fish pathogens. NIPPON SUISAN GAKKAISHI 83:4, pages 554-557.
Crossref
Yulia V. Kuzmenko, Elizaveta S. Starodubova, Anastasia S. Shevtsova, Liubov L. Chernokhaeva, Anastasia A. Latanova, Olga V. Preobrazhenskaia, Andrey V. Timofeev, Galina G. Karganova & Vadim L. Karpov. (2017) Intracellular degradation and localization of NS1 of tick-borne encephalitis virus affect its protective properties. Journal of General Virology 98:1, pages 50-55.
Crossref
Dibyadyuti Datta, Geetha P. Bansal, Dietlind L. Gerloff, Barry Ellefsen, Drew Hannaman & Nirbhay Kumar. (2017) Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation. Vaccine 35:2, pages 264-272.
Crossref
Hiroki Hayashi, jiao sun, Yuka Yanagida, Takako Ootera, Ritsuko Kubota-Koketsu, Tatsuo Shioda, Chikako Ono, Yoshiharu Matsuura, Hisashi Arase, Shota Yoshida, Ryo Nakamaru, Nan Ju, Ryoko Ide, Akiko Tenma, Sotaro Kawabata, Takako Ehara, Makoto Sakaguchi, Hideki Tomioka, Munehisa Shimamura, Sachiko Okamoto, Yasunori Amaishi, Hideto Chono, Junichi Mineno, Takao Komatsuno, Yoshimi Saito, Hiromi Rakugi, Ryuichi Morishita & Hironori Nakagami. (2021) Preclinical Study of DNA Vaccines Targeting SARS-CoV-2. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.